BriaCell intends to launch a spinoff to accelerate its drug development activities


Plans are for the spinoff company to be operated at BriaCell’s business headquarters in Philadelphia, where the company has space at B+Labs in Cira Centre.

Previous Nationwide Children's surpasses $200M in tech commercialization income
Next Well-known downtown Dayton restaurant will close doors by the end of the month